Integra LifeSciences Holdings Corporation Interest Expense 2011-2026 | IART

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Integra LifeSciences Holdings Corporation

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
3.94 M	3.72 M	12 M	50.4 M	71.6 M	54 M	64.7 M	35 M	25.8 M	23.5 M	22 M	19.7 M	22.2 M	27.6 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
71.6 M	3.72 M	31.2 M

Quarterly Interest Expense Integra LifeSciences Holdings Corporation

2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-1.95 M	-144 K	2.11 M	1.44 M	-610 K	471 K	-155 K	12.1 M	-	12.8 M	12.2 M	11.7 M	-	12.2 M	13.1 M	12.9 M	-	20.8 M	15.7 M	17.8 M	-	14 M	13.4 M	13.1 M	-	14.5 M	17.5 M	18.8 M	-	6.76 M	6.18 M	5.13 M	-	6.3 M	6.59 M	6.37 M	-	6.46 M	5.48 M	5.47 M	-	5.91 M	5.38 M	5.14 M	-	5.32 M	4.96 M	4.8 M	-	5.55 M	7.1 M	7.93 M	-	7.59 M	6.72 M	5.47 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
20.8 M	-1.95 M	8.19 M

Interest Expense of other stocks in the Medical devices industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Acutus Medical AFIB	5.66 M	-	-26.83 %	$ 2.62 M	USA
LivaNova PLC LIVN	664 K	$ 69.84	1.14 %	$ 3.79 B	Britain
Allied Healthcare Products AHPI	191 K	-	3.58 %	$ 2.21 M	USA
Cognyte Software Ltd. CGNT	-1.61 M	$ 6.61	3.44 %	$ 475 M	Israel
Apollo Endosurgery APEN	4.67 M	-	-	$ 475 M	USA
Alphatec Holdings ATEC	45.9 M	$ 13.85	-0.57 %	$ 2.08 B	USA
Avinger AVGR	1.72 M	-	-20.74 %	$ 369 K	USA
AxoGen AXGN	167 K	$ 31.25	-3.85 %	$ 1.44 B	USA
Axonics Modulation Technologies AXNX	-2.43 M	-	-	$ 3.31 B	USA
Aziyo Biologics AZYO	5.8 M	-	1.37 %	$ 20.5 M	USA
Apyx Medical Corporation APYX	2.48 M	$ 3.46	-2.26 %	$ 120 M	USA
Conformis CFMS	2.02 M	-	-	$ 16.4 M	USA
Bio-Rad Laboratories BIO	48.9 M	$ 269.55	0.25 %	$ 7.61 B	USA
BIOLASE BIOL	-1 K	-	-13.19 %	$ 166 K	USA
EDAP TMS S.A. EDAP	232 K	$ 4.63	3.58 %	$ 173 M	France
Bruker Corporation BRKR	-38.2 M	$ 39.92	0.38 %	$ 5.95 K	USA
BioSig Technologies BSGM	23 K	-	37.08 %	$ 85.7 M	USA
Boston Scientific Corporation BSX	349 M	$ 74.02	-1.5 %	$ 110 B	USA
ClearPoint Neuro CLPT	-40 K	$ 15.18	4.3 %	$ 410 M	USA
CONMED Corporation CNMD	31.1 M	$ 46.01	-0.07 %	$ 1.43 B	USA
Cardiovascular Systems CSII	1.63 M	-	0.15 %	$ 844 M	USA
Neovasc NVCN	133 K	-	-	$ 111 M	Canada
Cutera CUTR	-244 K	-	-10.19 %	$ 1.99 M	USA
Delcath Systems DCTH	-30 K	$ 10.16	2.11 %	$ 290 M	USA
Dynatronics Corporation DYNT	410 K	-	14.99 %	$ 929 K	USA
Eargo EAR	549 K	-	-	$ 10.2 M	USA
Electromed ELMD	78 K	$ 23.53	1.64 %	$ 199 M	USA
Second Sight Medical Products EYES	1.19 M	-	-0.97 %	$ 54.4 M	USA
Establishment Labs Holdings ESTA	-15.3 M	$ 77.39	-2.87 %	$ 2.18 B	Costa-rica
FONAR Corporation FONR	347 K	$ 18.54	-0.16 %	$ 122 M	USA
Globus Medical GMED	3.41 M	$ 95.57	3.99 %	$ 12.9 B	USA
Profound Medical Corp. PROF	146 K	$ 7.35	2.79 %	$ 180 M	Canada
Helius Medical Technologies HSDT	46.9 K	$ 2.18	17.84 %	$ 1.33 M	USA
IRadimed Corporation IRMD	164 K	$ 100.38	1.3 %	$ 1.27 B	USA
Invacare Corporation IVC	28.5 M	-	-	$ 24.7 M	USA
Inogen INGN	850 K	$ 6.07	3.94 %	$ 144 M	USA